Using a nanoparticle-based approach, researchers have succeeded in triggering the formation of regulatory T cells in animal models of multiple autoimmune diseases. If the findings, which were published in the Feb. 17, 2016, advance online issue of Nature, pan out clinically, it may be possible to halt or reverse autoimmune disease by specifically dampening the maladaptive autoimmune response.